Opioid-related disorder
Drug research and approvals for opioid-related disorder: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 224 studies of opioid-related disorder are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.
- Recruiting worldwide: 224
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
- Group Antenatal Healthcare, Education, and RecoveryNCT07944053 · Not applicable · Thomas Jefferson University · starts Nov 1, 2026
- Pain Sensitivity, Alcohol-Induced Analgesia, and Heavy Drinking in Individuals With Opioid Use DisorderNCT07894276 · Early Phase 1 · Ohio State University · starts Nov 12, 2026
- Cannabidiol in Opioid Use Disorder and Chronic Pain With BuprenorphineNCT07886606 · Early Phase 1 · Yale University · starts Dec 8, 2021
- A Study of Cebranopadol for Opioid Withdrawal Symptoms in Adults With Chronic PainNCT07874620 · Phase 2 · Adneuris Therapeutics, Inc. · starts Oct 1, 2026
- Helping Kentuckians Overcome Depression and Opioid Addiction With Brain StimulationNCT07842601 · Not applicable · University of Kentucky · starts Nov 11, 2026
- Pilot Testing of the emPath Platform to Improve Medication for Opioid Use Disorder (MOUD) Linkage and Retention Among…NCT07810322 · Not applicable · Duke University · starts Jul 29, 2026
- Characterization of CB1 Receptors Using [11-C]OMAR in Opioid Use DisorderNCT07800520 · Phase 1 · Yale University · starts Oct 1, 2026
- Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 3NCT07793383 · Not applicable · Yale University · starts Aug 17, 2026
- Supporting Treatment for Opioids and Recovery Capital (STORC) - R61 PhaseNCT07787039 · Not applicable · Friends Research Institute, Inc. · starts Sep 26, 2026
How its trials ended
1,278 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 257 whose ending is known, 49% met their primary endpoint, 3% missed it and 48% stopped early.
- Completed, result not reported59146%
- Ongoing36428%
- Met its primary endpoint12610%
- Stopped: other or unclear877%
- Status unknown665%
- Stopped: funding121%
- Stopped: enrollment or feasibility111%
- Missed its primary endpoint81%
- Stopped: lack of efficacy71%
- Stopped: sponsor or business decision6<1%
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA